PharmaCyte Biotech, Inc. (PMCB)
NASDAQ: PMCB · Real-Time Price · USD
1.640
0.00 (0.00%)
Dec 20, 2024, 4:00 PM EST - Market closed

PharmaCyte Biotech Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
2
Market Cap
11.43M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Apr 30, 2024---
Apr 30, 2023---
Apr 30, 2022---
Apr 30, 2021---
Apr 30, 2020---
Apr 30, 2019 Pro Pro Pro
Apr 30, 2018 Pro Pro Pro
Apr 30, 2017 Pro Pro Pro
Apr 30, 2016 Pro Pro Pro
Apr 30, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
STRATA Skin Sciences 32.68M
Sol-Gel Technologies 11.71M
Immuron 3.27M
Lyra Therapeutics 1.47M
AIM ImmunoTech 190.00K
Revenue Rankings